Advanced NanoTherapies Secures Financing for SirPlux Duo DCB Therapy

June 2, 2026—Advanced NanoTherapies, Inc. (ANT), which is developing the SirPlux Duo drug-coated balloon therapy for coronary and peripheral applications, announced the closing of a Series B financing totaling more than $31 million.

Mentice and Siemens Partner on Neurovascular Treatment Planning

June 2, 2026—Mentice AB announced a comarketing agreement with Siemens Healthineers to allow clinicians access to the Mentice Ankyras clinical decision-support software for intracranial aneurysms with the Siemens Healthineers Artis Icono angiography systems.

SIR Publishes Practice Guidance for PAE

June 2, 2026—The Society of Interventional Radiology (SIR) published a new practice guidance on prostate artery embolization (PAE) for the treatment of benign prostatic hyperplasia (BPH).

J&J Receives CE Mark Approvals for Cereglide Aspiration Devices for Stroke Treatment

June 2, 2026—Johnson & Johnson (J&J) announced it has received CE Mark approvals for its Cereglide 42 and Cereglide 57 aspiration catheters.

Cercare Receives FDA Clearance for CBCT Perfusion, Collaborates With Siemens on Acute Stroke Care

May 29, 2026—Cercare Medical, a developer of neuroimaging software, announced FDA 510(k) clearance for the company’s Cone-Beam CT Perfusion (CBCT-P) solution, which is intended to enable qualitative perfusion assessment directly from cone-beam CT data acquired during neurointerventional procedures.

AMPLIFI-1 Trial Launched for Amplifi Vein Dilation System in Distal AVF Creation

May 27, 2026—Amplifi Vascular announced the initiation of the AMPLIFI-1 pivotal trial evaluating the safety and effectiveness of the Amplifi vein dilation system, an investigational technology designed to facilitate distal arteriovenous fistula (AVF) creation for hemodialysis access.

Terumo Neuro’s HydroCoil Embolic System to Treat Ruptured Intracranial Aneurysms Studied in RAGE

May 27, 2026—Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced the publication of results from the RAGE study of ruptured aneurysms treated with hydrogel coils.

Microbot’s Liberty Endovascular Robotic System Receives Marketing Clearance in Israel

May 26, 2026—Microbot Medical Inc. announced that its Liberty endovascular robotic system has achieved regulatory marketing clearance from the Israel Ministry of Health’s AMAR Division.